+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Other Heterocycles 15811-21-9
15811-21-9,MFCD09868097
Catalog No.:AA001PWO

15811-21-9 | Spiro[2.5]octan-6-one

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
97%
in stock  
$102.00   $71.00
- +
250mg
95%
in stock  
$168.00   $118.00
- +
500mg
95%
in stock  
$280.00   $196.00
- +
1g
98%
in stock  
$534.00   $374.00
- +
5g
98%
in stock  
$1,580.00   $1,106.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA001PWO
Chemical Name:
Spiro[2.5]octan-6-one
CAS Number:
15811-21-9
Molecular Formula:
C8H12O
Molecular Weight:
124.1803
MDL Number:
MFCD09868097
SMILES:
O=C1CCC2(CC1)CC2
Properties
Computed Properties
 
Complexity:
133  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
9  
Hydrogen Bond Acceptor Count:
1  
XLogP3:
1.4  

Downstream Synthesis Route

[1]Mihovilovic;Chen;Wang;Kyte;Rochon;Kayser;Stewart[JournalofOrganicChemistry,2001,vol.66,#3,p.733-738]

[2]CurrentPatentAssignee:LGCHEMCO.,LTD.-WO2008/7930,2008,A1Locationinpatent:Page/Pagecolumn28-29

15811-21-9   
6-oxaspiro2.6nonan-7-one 

[1]Mihovilovic;Chen;Wang;Kyte;Rochon;Kayser;Stewart[JournalofOrganicChemistry,2001,vol.66,#3,p.733-738]

[1]D'Accolti,Lucia;Dinoi,Anna;Fusco,Caterina;Russo,Antonella;Curci,Ruggero[JournalofOrganicChemistry,2003,vol.68,#20,p.7806-7810]

[2]Galeotti,Marco;Vicens,Laia;Salamone,Michela;Costas,Miquel;Bietti,Massimo[JournaloftheAmericanChemicalSociety,2022,vol.144,#16,p.7391-7401]

[1]Mihovilovic;Chen;Wang;Kyte;Rochon;Kayser;Stewart[JournalofOrganicChemistry,2001,vol.66,#3,p.733-738]

[2]CurrentPatentAssignee:C.H.BoehringerSohnAG&Co.KG-WO2013/26163,2013,A1

[3]CurrentPatentAssignee:PHARMARONINC-WO2014/146490,2014,A1

[4]CurrentPatentAssignee:PHARMARONINC-WO2014/146246,2014,A1

[5]CurrentPatentAssignee:HANSOHPHARMACEUTICALGROUPCOLTD-WO2018/130174,2018,A1

[6]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2020/128768,2020,A1

[1]CurrentPatentAssignee:HANSOHPHARMACEUTICALGROUPCOLTD-WO2018/130174,2018,A1Locationinpatent:Page/Pagecolumn74-75

[2]CurrentPatentAssignee:IDORSIAPHARMACEUTICALSLTD-US2008/176926,2008,A1Locationinpatent:Page/Pagecolumn27

[3]CurrentPatentAssignee:IDORSIAPHARMACEUTICALSLTD-WO2006/100631,2006,A1Locationinpatent:Page/Pagecolumn72

[4]CurrentPatentAssignee:C.H.BoehringerSohnAG&Co.KG-WO2013/26163,2013,A1Locationinpatent:Page/Pagecolumn34-35

[5]Bolli,MartinH.;Velker,Jörg;Müller,Claus;Mathys,Boris;Birker,Magdalena;Bravo,Roberto;Bur,Daniel;DeKanter,Ruben;Hess,Patrick;Kohl,Christopher;Lehmann,David;Meyer,Solange;Nayler,Oliver;Rey,Markus;Scherz,Michael;Steiner,Beat[JournalofMedicinalChemistry,2014,vol.57,#1,p.78-97]

[6]CurrentPatentAssignee:PHARMARONINC-WO2014/146490,2014,A1Locationinpatent:Page/Pagecolumn117

[7]CurrentPatentAssignee:PHARMARONINC-WO2014/146246,2014,A1Locationinpatent:Page/Pagecolumn97

[8]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2020/128768,2020,A1Locationinpatent:Page/Pagecolumn222;223

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 15811-21-9
10036-09-6

10036-09-6

 1004-77-9

1004-77-9

 1006-03-7

1006-03-7

 102402-84-6

102402-84-6

 114119-97-0

114119-97-0

 1193-47-1

1193-47-1
Building Blocks
More >
Tags:15811-21-9 Molecular Formula|15811-21-9 MDL|15811-21-9 SMILES|15811-21-9 Spiro[2.5]octan-6-one